Dx Deals: Outreach Deals by Quest, Labcorp Are Still Ramping Up
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains
From - National Intelligence Report
CMS's newly issued preliminary Clinical Laboratory Fee Schedule (CLFS) for 2018 dashes the lab industry's hopes for PAMA relief by making two things…
From - G2 Compliance Advisor
The following scenario comes right out of an August 25, 2017 OIG Advisory Opinion. See if you can guess how the OIG ruled…
By Dan Scungio, MT (ASCP), SLS, CQA (ASQ) bio
Memorizing what actions to take in a fire situation is important, and reviewing this topic in October, National Fire Prevention Month, is both timely and…
From - G2 Compliance Advisor
Before civil rights laws, job ads like these were seen as perfectly normal. Today, employers aren't allowed to post job ads with phrases that exclude or express preferences based on…
From - G2 Compliance Advisor
In the grand scheme of things, $2 million is fairly small potatoes for false billing of lab tests—especially considering that it allegedly…
From - Laboratory Industry Report
The health care industry has raised $5 billion in venture fund investment in the first half of 2017 and is well on pace to smash the single year record of…
From - National Intelligence Report
Some of the labs that participate in TRICARE got some good news when the Department of Defense announced that it has extended the so called…
From - Laboratory Industry Report
The diagnostics community is saying goodbye to a frenemy of 25 years. On Aug. 29, Alberto Gutierrez, director of the…
From - G2 Compliance Advisor
Based on the enforcement track record, if your lab ever gets charged with falsely billing Medicare for lab tests, failure to document the…
By Lâle White bio
As XIFIN predicted, the PAMA reporting exercise has resulted in significant proposed laboratory fee cuts. In fact…